Valuation: Embracing Future Holdings Limited

Market Cap 55.47M 43.36M 38.54M 35.73M 32.5M 61.34M 4.12B 62.32M 429M 168M 2.15B 163M 159M 6.85B P/E 2024
-8.18x
P/E 2025 -22.5x
Enterprise Value 57.33M 44.81M 39.83M 36.92M 33.59M 63.39M 4.25B 64.41M 444M 174M 2.22B 168M 165M 7.08B EV / Sales 2024
58.8x
EV / Sales 2025 17.5x
Free-Float
44.94%
Yield 2024 *
-
Yield 2025 -
1 day+3.23%
1 week-8.57%
Current month-5.88%
1 month-13.51%
3 months-21.95%
6 months-45.76%
Current year-38.46%
1 week 0.03
Extreme 0.03
0.04
1 month 0.03
Extreme 0.03
0.04
Current year 0.03
Extreme 0.03
0.09
1 year 0.02
Extreme 0.021
0.09
3 years 0.01
Extreme 0.008
0.09
5 years 0.01
Extreme 0.008
0.22
10 years 0.01
Extreme 0.008
0.88
Manager TitleAgeSince
President 46 30/04/2024
Comptroller/Controller/Auditor 44 01/07/2024
Corporate Secretary - -
Director TitleAgeSince
Director/Board Member 64 14/06/2021
Director/Board Member 55 31/03/2023
Director/Board Member 70 27/11/2023
Date Insider Type Main position Quantity % Market Cap. Importance
30/04/21 Exercice

Chairman

330,000 0.1250%
19/08/20 Free

Chairman

1,130,000 0.4340%
Change 5-day change 1-year change 3-year change Capi.($)
+3.23%-8.57%+39.13%+100.00% 43.36M
-0.93%+4.86%+28.54%+41.24% 255B
-1.06%+4.20%+8.59%+8.83% 161B
-0.27%+0.65%-1.82%+55.64% 151B
+0.57%+3.88%-54.60%-11.40% 64.33B
+1.47%+5.90%-12.94%-13.05% 51.9B
-1.70%+1.63%+19.20%+21.51% 49.92B
-0.85%+4.81%+6.02%+46.42% 50.25B
-1.47%+1.42%+22.59%+55.13% 48.77B
-1.62%+0.73%+30.48%+71.24% 42.93B
Average -0.26%+2.42%+8.52%+37.56% 87.5B
Weighted average by Cap. -0.69%+4.13%+9.01%+32.09%

Financials

2024 2025
Net sales 858K 671K 596K 553K 503K 949K 63.66M 964K 6.64M 2.6M 33.22M 2.52M 2.46M 106M 5.26M 4.11M 3.66M 3.39M 3.08M 5.82M 390M 5.91M 40.73M 15.97M 204M 15.43M 15.11M 649M
Net income -3.43M -2.68M -2.39M -2.21M -2.01M -3.8M -255M -3.86M -26.59M -10.42M -133M -10.07M -9.86M -424M -3.96M -3.1M -2.75M -2.55M -2.32M -4.38M -294M -4.45M -30.67M -12.03M -153M -11.62M -11.38M -489M
Net Debt 1.46M 1.14M 1.01M 937K 853K 1.61M 108M 1.63M 11.26M 4.42M 56.33M 4.27M 4.18M 180M 1.86M 1.45M 1.29M 1.2M 1.09M 2.05M 138M 2.09M 14.37M 5.63M 71.86M 5.45M 5.33M 229M
Projected Income Statement - Annual - Embracing Future Holdings Limited
Logo Embracing Future Holdings Limited
Embracing Future Holdings Ltd, formerly Biolidics Limited, is a precision medicine medical technology company. Its principal activities are technology development, technology transfer, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services and investment holding. Its segments are Cancer, Infectious diseases, Laboratory services, and Corporate segments. Its Cancer and infectious diseases segments involve identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship networks and direct customers in the cancer field, and the infectious diseases field. The Laboratory services segment involves business, operation, and provision of laboratory services to customers. The laboratory has regulatory approval from Singapore’s Ministry of Health for testing for COVID-19 in Singapore.
Employees
-
Date Price Change Volume
16/10/26 SGD 0.0320 +3.23% 1,256,900
15/10/26 SGD 0.0310 -6.06% 2,035,100
14/10/26 SGD 0.0330 0.00% 2,407,800
13/10/26 SGD 0.0330 -5.71% 460,000
12/10/26 SGD 0.0350 0.00% 2,100